These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1455 related items for PubMed ID: 9894758

  • 1. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z, Takahashi M, Aoki S, Toba K, Liu A, Osman Y, Takahashi H, Tsukada N, Suzuki N, Nikkuni K, Furukawa T, Koike T, Aizawa Y.
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [Abstract] [Full Text] [Related]

  • 2. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R, Andreeff M.
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [Abstract] [Full Text] [Related]

  • 3. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
    Costello RT, Mallet F, Chambost H, Sainty D, Gastaut JA, Olive D.
    Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
    [Abstract] [Full Text] [Related]

  • 4. The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon.
    Tsukada N, Aoki S, Maruyama S, Kishi K, Takahashi M, Aizawa Y.
    J Exp Clin Cancer Res; 1997 Jun; 16(2):171-6. PubMed ID: 9261743
    [Abstract] [Full Text] [Related]

  • 5. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M, Reif S, Hecht K, Pelka-Fleischer R, Kroell T, Pfister K, Schmetzer H.
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [Abstract] [Full Text] [Related]

  • 6. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S, Fleischer RP, Kroell T, Schmid C, Zitzelsberger H, Salih H, de Valle F, Treder W, Schmetzer HM.
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [Abstract] [Full Text] [Related]

  • 7. Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.
    Schmitt M, Li L, Giannopoulos K, Chen J, Brunner C, Barth T, Schmitt A, Wiesneth M, Döhner K, Döhner H, Greiner J.
    Exp Hematol; 2006 Dec; 34(12):1709-19. PubMed ID: 17157168
    [Abstract] [Full Text] [Related]

  • 8. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
    Bruserud O, Ulvestad E.
    Cell Immunol; 2000 Nov 25; 206(1):36-50. PubMed ID: 11161436
    [Abstract] [Full Text] [Related]

  • 9. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Li L, Schmitt A, Reinhardt P, Greiner J, Ringhoffer M, Vaida B, Bommer M, Vollmer M, Wiesneth M, Döhner H, Schmitt M.
    Cancer Immun; 2003 Jul 16; 3():8. PubMed ID: 12862419
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C, Loher F, Zang C, Ismair MG, Petrides PE.
    Clin Cancer Res; 1999 May 16; 5(5):1115-24. PubMed ID: 10353746
    [Abstract] [Full Text] [Related]

  • 11. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
    Wu CY, Zhang LS, Zhang YF, Chai Y, Yi LC, Song FX.
    Ai Zheng; 2005 Apr 16; 24(4):425-31. PubMed ID: 15820064
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens.
    Li L, Reinhardt P, Schmitt A, Barth TF, Greiner J, Ringhoffer M, Döhner H, Wiesneth M, Schmitt M.
    Cancer Immunol Immunother; 2005 Jul 16; 54(7):685-93. PubMed ID: 15627212
    [Abstract] [Full Text] [Related]

  • 13. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 16; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 14. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
    Kurzrock R, Kantarjian H, Wetzler M, Estrov Z, Estey E, Troutman-Worden K, Gutterman JU, Talpaz M.
    Exp Hematol; 1993 Jan 16; 21(1):80-5. PubMed ID: 8417962
    [Abstract] [Full Text] [Related]

  • 15. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M.
    Neoplasma; 1993 Jan 16; 40(5):275-81. PubMed ID: 8272155
    [Abstract] [Full Text] [Related]

  • 16. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ, Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, Humphries K, Largman C.
    Exp Hematol; 1995 Oct 16; 23(11):1160-6. PubMed ID: 7556525
    [Abstract] [Full Text] [Related]

  • 17. Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells.
    Bruserud O, Ulvestad E.
    Cancer Immunol Immunother; 2003 Apr 16; 52(4):215-25. PubMed ID: 12669246
    [Abstract] [Full Text] [Related]

  • 18. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT, Mallet F, Sainty D, Maraninchi D, Gastaut JA, Olive D.
    Eur J Immunol; 1998 Jan 16; 28(1):90-103. PubMed ID: 9485189
    [Abstract] [Full Text] [Related]

  • 19. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
    Foreman KE, Wrone-Smith T, Krueger AE, Nickoloff BJ.
    Clin Immunol; 1999 Jun 16; 91(3):345-53. PubMed ID: 10370381
    [Abstract] [Full Text] [Related]

  • 20. P53 protein expression in human leukemia and lymphoma cells.
    Koníková E, Kusenda J.
    Neoplasma; 2001 Jun 16; 48(4):290-8. PubMed ID: 11712681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.